Data / Partner portfolio / United Nations / World Health Organization
Authoritative guidance and standards on quality, safety and efficacy
Published title: Provision of authoritative guidance and standards on quality, safety and efficacy of health products, essential medicines and diagnostics lists
US$ millions unless stated. Haitian fiscal year, October to September. FY2026-27 began October 1, 2026.
Description
The Secretariat will support countries to: adapt norms, standards and guidance on the quality, safety and efficacy of health products, essential medicines and diagnostics lists to national contexts; and build capacity to implement the relevant guidance and standards. In producing global public health goods, the Secretariat will: allocate and issue international nonproprietary names to facilitate the identification of active pharmaceutical substances; develop, review and update model lists of essential health products, including essential medicines; essential in vitro diagnostics; and assistive technology products, such as medicines for noncommunicable diseases, primary health care and emergency services; develop and update the international pharmacopoeia and international chemical reference standards that are adopted by WHO expert committees in order to harmonize the quality specifications of
more
pharmaceuticals; develop and maintain guidelines for the Biowaiver List in order to provide information on how to show that a multisource (generic) pharmaceutical is interchangeable in terms of its quality, efficiency, safety and therapeutic equivalence to the original product; develop strategies for the selection and management of blood products and organ replacement therapies; provide guidance for the appropriate, rational and safe use of medical products, vaccines, medical devices and assistive technology; and develop policies and guidelines on improving the governance and stewardship of health products, including the delivery of pharmaceutical services.
- Sector
- Health
- Stage
- Closed since December 31, 2023
- Start
- January 1, 2022
- Closing
- December 31, 2023
- Effectiveness
- Not reported
- Departments
- Ouest
- Last transaction
- December 31, 2023
- IATI identifier
Life cycle4 stages, 7 dates
Stage history
| Stage | From |
|---|---|
| Approved | January 1, 2022 |
| Under way | January 1, 2022 |
| Closing | December 31, 2023 |
| Closed | December 31, 2023 |
Dated events
| Event | Date | Source |
|---|---|---|
| Actual start | January 1, 2022 | IATI |
| First commitment | January 1, 2022 | Transactions |
| Planned start | January 1, 2022 | IATI |
| Actual end | December 31, 2023 | IATI |
| First disbursement | December 31, 2023 | Transactions |
| Last disbursement | December 31, 2023 | Transactions |
| Closing date | December 31, 2023 | IATI |
Financing
Table 1.Position at the data date by source (stocks), US$ millions
| This pageUS$ millions | Source | |
|---|---|---|
| Commitment | 0.1 | IATI |
| Disbursed | <0.1 | IATI |
| Undisbursed | Not reported | |
| Total cost | Not reported |
IATI amounts. Approved: The commitments the partner reports, converted to US$. Disbursed to date: The disbursements (IATI transaction type 3, money paid to another organization) and expenditure (type 4, money the publisher spent itself) the partner reports, converted to US$. Undisbursed: The undisbursed balance the record gives, where the partner reports one, in US$. Amounts by source
Incoming funds as the agencies report them: received, or committed where an agency reports no receipt from that provider. UN agencies' core resources and UN pooled funds appear among the funding partners on the Disbursements and Commitments pages.
Table 2.Funding received for this operation, by provider, US$ millions
| Provider | FY2025-26 | FY2026-27to Oct 18 | Since 2022US$ millions |
|---|---|---|---|
| UN agencies' core resourcesincludes incoming commitments | Not reported | None to date | <0.1 |
Largest providers
| Provider | FY2025-26 | FY2026-27to Oct 18 | Since 2022US$ millions |
|---|---|---|---|
| Core and flexible resourcesUN agencies' core resourcesincludes incoming commitments | Not reported | None to date | <0.1 |
Changes to the operationnot reported
- Original closing date
- Not reported
- Closing date extensions
- Not reported
- Restructurings
- Not reported
- Emergency component
- Not reported
New commitments and disbursements by fiscal year
Table 3.New commitments and disbursements by fiscal year (flows), US$ millions
| FY2021-22US$ millions | FY2023-24US$ millions | |
|---|---|---|
| New commitments | 0.1 | Not reported |
| Disbursements | Not reported | <0.1 |
| Cumulative disbursements | Not reported | <0.1 |
Records and documents
Transactions2 records, January 1, 2022 to December 31, 2023
Table 4.Transactions, US$ millions
Terms5 of 6 reported
- Finance type
- 110 Standard grant
- Flow type
- 10 Official development assistance
- Aid type
- B03 Contributions to specific-purpose programs and funds managed by implementing partners
- Tied status
- 5 Untied
- Collaboration type
- 4 Multilateral outflows
- Humanitarian
- Not reported
Policy markers2 policy markers
| Policy marker | Significance | Source |
|---|---|---|
| 3.8 Universal health coverage | Not reported | IATI |
| 3.B Research on and access to vaccines and medicines | Not reported | IATI |
Locations1 department, 1 place named, 1 place with coordinates
| Departments | Ouest |
| Places named by the source | Port-au-Prince |
| Places with coordinates | 1 |
Identifiers1 identifier
| System | Identifier | Source |
|---|---|---|
| IATI identifier | XM-DAC-928-HT-2022-23-01.003.AM01.HTI01 | IATI |
Partner documents
- Budget, open.who.int
- 2022-2023 WHO Results Report_Haiti_Country profile, who.int
Sources
- IATI record (d-portal): terms of use set by the publisher
- Transactions: terms of use set by the publisher
Data as of October 18, 2026
| Source | Read on |
|---|---|
| IATI | October 18, 2026 |
Cite this page
HaitiDocs. Authoritative guidance and standards on quality, safety and efficacy. Partner portfolio, data as of October 18, 2026. https://www.haitidocs.org/portfolio/projects/IATI%3AXM-DAC-928-HT-2022-23-01.003.AM01.HTI01